PHENIDIN 18 MG

Country: Israel

Language: English

Source: Ministry of Health

Active ingredient:

METHYLPHENIDATE HYDROCHLORIDE

Available from:

TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD

ATC code:

N06BA04

Pharmaceutical form:

TABLETS PROLONGED RELEASE

Composition:

METHYLPHENIDATE HYDROCHLORIDE 18 MG

Administration route:

PER OS

Prescription type:

Required

Manufactured by:

DEVELCO PHARMA GMBH, GERMANY

Therapeutic area:

METHYLPHENIDATE

Therapeutic indications:

For the treatment of attention deficit hyperactivity disorder (ADHD).

Authorization date:

2023-11-30

Patient Information leaflet

Patient leaflet in accordance with the Pharmacists’
Regulations (Preparations) - 1986
This medicine is dispensed with a doctor’s prescription only
Phenidin
prolonged-release tablets
Each Phenidin 18 mg tablet contains:
methylphenidate hydrochloride 18 mg.
Each Phenidin 27 mg tablet contains:
methylphenidate hydrochloride 27 mg.
Each Phenidin 36 mg tablet contains:
methylphenidate hydrochloride 36 mg.
Each Phenidin 54 mg tablet contains:
methylphenidate hydrochloride 54 mg.
Inactive ingredients and allergens in this medicine – See section 2
under ‘Important information about some of this medicine’s
ingredients’
and section 6 – ‘Additional information’.
Read the entire leaflet carefully before you start using this
medicine.
This
leaflet
contains
concise
information
about
this
medicine. If you have any further questions, consult your doctor or
pharmacist.
This medicine has been prescribed for you. Do not pass it on to
others.
It may harm them, even if it seems to you that their medical condition
is similar to yours.
1. What is this medicine intended for?
Phenidin is intended for the treatment of attention deficit
hyperactivity
disorder (ADHD) in children over 6 years old, adolescents, and adults
up to 65 years old.
Phenidin
can
improve
attention
and
concentration
and
reduce
impulsivity and hyperactivity in people with ADHD.
Phenidin should be given as part of an ADHD treatment program that
may include counselling or other therapy.
Therapeutic group: central nervous system stimulant.
2. Before using this medicine
Do not use this medicine if:
you are sensitive (allergic) to the active ingredient (methylphenidate
hydrochloride) or to any of the other ingredients in this medicine
(see section 6 ‘Additional information’)
you are experiencing marked anxiety, mental tension, or agitation
you have an eye problem called glaucoma (increased intraocular
pressure)
you have tics or Tourette’s syndrome, or a family history of
Tourette’s syndrome. Tics are repetitive movements or sounds that
you cannot co